Fig. 3.

Survival of vaccinated mice post intranasal challenge with TIGR4. This figure shows survival of vaccinated mice following challenge with TIGR4. Mice were followed for disease progression, once clinical symptoms reached a designated endpoint mice were sacrificed. Experimental endpoint was 7 days post challenge (168 h) and surviving mice were sacrificed at this time point. n = 5 mice/group bar AcrA-SP4 P1 where n = 3 and AcrA-SP4 P2 where n = 4. Statistical analysis was performed in GraphPad Prism using a Log-rank Test (P < 0.05).